Former vice presidential candidate Geraldine Ferraro, who died on Saturday at age 75 of the incurable blood cancer called multiple myeloma, and Richard J. "Rick" Corman, 55, whom FORTUNE profiled in its March 21 issue, knew each other because they had met at Dana-Farber Cancer Institute in Boston, where both were fighting this killer disease. They in fact had the same set of doctors, Kenneth Anderson, director of the institute's multiple-myeloma practice, and his colleague, Paul Richardson.
Firefighter Randy Wiebicke who, like so many New York City firefighters, toiled in and around ground zero in the months after 9/11, died Wednesday following a nearly three-year battle with multiple myeloma, an aggressive and fatal blood cancer.
Celgene, the drug company that's cornered the market for blood cancer treatment, continues to wow investors with its constantly climbing stock price, and analysts expect the good times to keep rolling.
Thalomid, formerly the bane of the pharmaceutical industry as a dangerous pregnancy painkiller, has gotten a second life and could help fast-growing Celgene corner the market as a blood cancer treatment.